查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401006

泌尿道感染治疗市场，按药物、适应症、配销通路、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Urinary Tract Infection Therapeutics Market, By Drug, By Indication, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 277 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，泌尿道感染治疗市场规模为 72 亿美元，2023 年至 2030 年CAGR为 2.50%。

尿路感染治疗市场-市场动态

对抗生素抗药性的日益担忧推动市场需求

随着引起泌尿道感染的细菌对常用抗生素产生抗药性，迫切需要开发新的、更有效的疗法。这推动了研究和开发工作，以确定新的抗菌药物，研究疫苗接种等替代治疗方式，并鼓励负责任地使用抗生素以减少抗药性。日益严重的抗生素抗药性尿路感染问题鼓励製药公司、研究人员和医疗保健专业人员探索创造性的方法，以保持尿路感染的可控性，并使患者即使在细菌抗药性不断发展的情况下也能接受有效的治疗。

尿路感染治疗市场 - 关键见解

根据我们的研究分析师分享的分析，预计全球泌尿道感染治疗市场在预测期内（2023-2030）每年将以 2.50% 左右的CAGR成长

由于对抗生素抗药性的日益担忧，尿路感染治疗产业预计将以显着的速度成长。

根据药物细分，青霉素及其组合药物预计将在 2022 年显示最大的市场份额

根据适应症细分，复杂性泌尿道感染是 2022 年的领先药物

按地区划分，北美是 2022 年的主要收入来源

尿路感染治疗市场区隔分析：

全球尿路感染治疗市场根据药物、适应症、配销通路和地区进行细分。

市面上依药物分为五类：青霉素及其组合、喹诺酮类、头孢菌素、唑类及两性霉素 B、硝基呋喃类、其他。青霉素及其复方药物在市场上占据主导地位。由于青霉素和组合药物能够有效治疗某些引起泌尿道感染的细菌，因此作为泌尿道感染 (UTI) 治疗方法的需求量很大。这些抗生素是治疗无併发症泌尿道感染的治疗手段的一部分，为患者和医疗保健专业人员提供治疗这些常见疾病的可靠替代方案。

市场依适应症分为三类：复杂性泌尿道感染、非复杂性泌尿道感染、其他。复杂性尿路感染领域在市场中占据主导地位，并可能在预测期内保持其主导地位。由于青霉素和组合药物能够有效治疗某些引起泌尿道感染的细菌，因此作为泌尿道感染 (UTI) 治疗方法的需求量很大。这些抗生素是治疗无併发症泌尿道感染的治疗手段的一部分，为患者和医疗保健专业人员提供治疗这些常见疾病的可靠替代方案。

泌尿道感染治疗市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太地区以及中东和非洲地区。这些区域根据开展业务的国家进一步划分。有几个变数会影响亚太地区对泌尿道感染 (UTI) 药物的需求。该地区的高人口密度和城市化导致尿路感染增加，因为更多地暴露于可能的危险因素。此外，医疗保健设施的改善和医疗服务的可近性改善了诊断和治疗，并提高了人们对泌尿道感染的认识。此外，生活方式和营养的改变也可能导致泌尿道感染。最后，人口老化使得泌尿道感染的可能性更大。随着医疗保健意识的增强和对有效药物的需求的增加，製药公司和医疗保健专业人员正在将泌尿道感染视为亚太地区的关键公共卫生问题。

尿路感染治疗市场-竞争格局：

泌尿道感染 (UTI) 药物的竞争环境中充斥着製药公司，它们都在争夺这块蛋糕。此外，常用抗生素的通用版本通常是可以获得的。新创公司和小型企业也透过开发新的治疗和预防方法为该行业做出贡献。随着人们对抗生素抗药性的担忧加剧，公司正专注于研究生产新的、更有效的泌尿道感染药物。市场竞争推动了替代药物、疫苗接种和非抗生素技术的发展，为患者提供了更多的泌尿道感染治疗选择。

最近的发展：

2023年4月，英国製药公司葛兰素史克（GSK.L）透露，其用于治疗成年女性和青少年单纯性泌尿道感染（uUTI）的口服抗生素药物实现了后期研究的主要目标。据製造商称，这种药物 Gepotidacin 实现了与呋喃妥因相当或更好的关键目标，呋喃妥因是目前治疗 uUTI 的护理方案。

目录

第一章：尿路感染治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 泌尿道感染治疗市场片段（按药物）
    • 泌尿道感染治疗市场片段（按适应症）
    • 按配销通路的尿路感染治疗市场片段
    • 按国家/地区分類的泌尿道感染治疗市场片段
    • 按地区分類的泌尿道感染治疗市场片段
  • 竞争洞察

第 3 章：泌尿道感染治疗主要市场趋势

  • 尿路感染治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 尿路感染治疗市场限制
    • 市场限制影响分析
  • 尿路感染治疗市场机会
  • 尿路感染治疗市场未来趋势

第 4 章：泌尿道感染治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：泌尿道感染治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：泌尿道感染治疗市场格局

  • 2022 年泌尿道感染治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：泌尿道感染治疗市场 - 按药物

  • 概述
    • 按药物分類的细分市场份额分析
    • 青霉素及其组合
    • 奎诺酮类
    • 头孢菌素
    • 唑类和两性霉素 B
    • 硝基呋喃类
    • 其他的

第 8 章：泌尿道感染治疗市场 - 按适应症

  • 概述
    • 按指标分類的细分市场占有率分析
    • 复杂性泌尿道感染
    • 单纯性泌尿道感染
    • 其他的

第 9 章：泌尿道感染治疗市场 - 按配销通路

  • 概述
    • 按配销通路分類的细分市场份额分析
    • 医院
    • 药局
    • 妇科及泌尿科诊所

第 10 章：泌尿道感染治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美尿路感染治疗药物主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按药物）
    • 北美市场规模和预测（按指标）
    • 北美市场规模和预测（按配销通路）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲泌尿道感染治疗药物主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按药品）
    • 欧洲市场规模与预测（按指标）
    • 欧洲市场规模和预测（按配销通路）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区泌尿道感染治疗药物主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区药物市场规模与预测
    • 亚太地区市场规模与预测（依指标）
    • 亚太地区市场规模和预测（按配销通路）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲尿路感染治疗药物主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按药品）
    • 拉丁美洲市场规模与预测（按指标）
    • 拉丁美洲市场规模和预测（按配销通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲泌尿道感染治疗药物主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按药品）
    • 中东和非洲市场规模及预测（依指标）
    • 中东和非洲市场规模及预测（按配销通路）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 泌尿道感染治疗产业

  • 竞争仪表板
  • 公司简介
    • AstraZeneca
    • GlaxoSmithKline
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Allergan
    • Novartis
    • Bayer AG
    • Johnson & Johnson
    • Ferring Pharmaceuticals
    • Cipla
    • Sun Pharmaceutical Industries
    • Lupin Limited
    • Teva Pharmaceuticals
    • Dr. Reddy's Laboratories
    • Zydus Cadila

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1970

REPORT HIGHLIGHT

Urinary Tract Infection Therapeutics Market size was valued at USD 7,200 Million in 2022, expanding at a CAGR of 2.50 % from 2023 to 2030.

Urinary tract infection (UTI) therapies are a group of medical treatments and pharmacological interventions used to diagnose, prevent, and treat infections of the urinary system. UTIs are caused by bacterial infections in the bladder or urethra, which cause symptoms including pain, frequent urination, and discomfort. UTI treatments include antibiotics such as nitrofurantoin and ciprofloxacin, which target and kill the infection-causing bacteria. Additionally, supportive therapies may include analgesics for discomfort alleviation and infection prevention techniques. UTI treatments are critical in giving comfort, avoiding complications such as kidney infections, and increasing the quality of life for those suffering from these prevalent and sometimes severe diseases.

Urinary Tract Infection Therapeutics Market- Market Dynamics

Growing concern over antibiotic resistance propel market demand

As the bacteria that cause UTIs gain resistance to frequently used antibiotics, there is an urgent need for the development of new and more effective therapies. This has fueled research and development efforts to identify new antimicrobial drugs, investigate alternative treatment modalities such as vaccinations, and encourage responsible antibiotic usage in order to reduce resistance. The growing issue of antibiotic-resistant UTIs encourages pharmaceutical firms, researchers, and healthcare professionals to explore creative ways to keep UTIs manageable and patients receiving effective therapy even as bacterial resistance evolves.

Urinary Tract Infection Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global Urinary Tract Infection Therapeutics market is estimated to grow annually at a CAGR of around 2.50% over the forecast period (2023-2030)

The Urinary Tract Infection Therapeutics industry is projected to grow at a significant rate due to growing concern over antibiotic resistance.

Based on Drug segmentation, Penicillin and Combinations was predicted to show maximum market share in the year 2022

Based on Indication segmentation, Complicated UTI was the leading Drug in 2022

On the basis of region, North America was the leading revenue generator in 2022

Urinary Tract Infection Therapeutics Market- Segmentation Analysis:

The Global Urinary Tract Infection Therapeutics Market is segmented on the basis of Drug, Indication, Distribution Channel, and Region.

The market is divided into five categories based on Drug: Penicillin and Combinations, Quinolones, Cephalosporin, Azoles and Amphotericin B, Nitrofurans, Others. The Penicillin and Combinations dominates the market. Because of their efficiency in treating some UTI-causing bacteria, penicillin and combination medicines are in high demand as urinary tract infection (UTI) therapies. These antibiotics are part of the treatment arsenal for uncomplicated UTIs, providing patients and healthcare professionals with dependable alternatives for treating these prevalent illnesses.

The market is divided into three categories based on Indication: Complicated UTI, Uncomplicated UTI, Others. The Complicated UTI sector dominates the market and is likely to maintain its dominance during the forecast period. Because of their efficiency in treating some UTI-causing bacteria, penicillin and combination medicines are in high demand as urinary tract infection (UTI) therapies. These antibiotics are part of the treatment arsenal for uncomplicated UTIs, providing patients and healthcare professionals with dependable alternatives for treating these prevalent illnesses.

Urinary Tract Infection Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables impact the need for urinary tract infection (UTI) medicines in the Asia-Pacific area. The region's high population density and urbanization lead to a rise in UTIs owing to greater exposure to possible risk factors. Additionally, improved healthcare facilities and accessibility to medical services have resulted in improved diagnosis and treatment, as well as increased awareness of UTIs. Furthermore, lifestyle and nutritional changes may lead to UTIs. Finally, the growing older population makes UTIs more likely. Pharmaceutical firms and healthcare professionals are treating UTIs as a key public health problem in the Asia-Pacific region as healthcare awareness grows and demand for effective medicines increases.

Urinary Tract Infection Therapeutics Market- Competitive Landscape:

The competitive environment in urinary tract infection (UTI) medicines is crowded with pharmaceutical firms fighting for a piece of the pie. Furthermore, generic versions of commonly used antibiotics are generally accessible. Startups and smaller businesses also contribute to the industry by developing new treatment and preventative approaches. Companies are focused on research to produce new, more effective UTI medicines as worries about antibiotic resistance rise. The competition in the market pushes the development of alternative medicines, vaccinations, and non-antibiotic techniques, providing patients with a larger choice of UTI management alternatives.

Recent Developments:

In April 2023, GSK (GSK.L), a British pharmaceutical company, revealed that its oral antibiotic medication for treating uncomplicated urinary tract infections (uUTI) in female adults and adolescents fulfilled the primary objectives in late-stage studies. The medicine, gepotidacin, accomplished its key aims of being on par with or better than nitrofurantoin, the current course of care for the therapy of uUTIs, according to the manufacturer.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET KEY PLAYERS

  • AstraZeneca
  • GlaxoSmithKline
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Allergan
  • Novartis
  • Bayer AG
  • Johnson & Johnson
  • Ferring Pharmaceuticals
  • Cipla
  • Sun Pharmaceutical Industries
  • Lupin Limited
  • Teva Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Zydus Cadila

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY DRUG

  • Penicillin and Combinations
  • Quinolones
  • Cephalosporin
  • Azoles and Amphotericin B
  • Nitrofurans
  • Others

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY INDICATION

  • Complicated UTI
  • Uncomplicated UTI
  • Others

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL

  • Hospital
  • Pharmacies
  • Gynecology and Urology Clinics

GLOBAL URINARY TRACT INFECTION THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Urinary Tract Infection Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Urinary Tract Infection Therapeutics Market Snippet by Drug
    • 2.1.2. Urinary Tract Infection Therapeutics Market Snippet by Indication
    • 2.1.3. Urinary Tract Infection Therapeutics Market Snippet by Distribution Channel
    • 2.1.4. Urinary Tract Infection Therapeutics Market Snippet by Country
    • 2.1.5. Urinary Tract Infection Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Urinary Tract Infection Therapeutics Key Market Trends

  • 3.1. Urinary Tract Infection Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Urinary Tract Infection Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Urinary Tract Infection Therapeutics Market Opportunities
  • 3.4. Urinary Tract Infection Therapeutics Market Future Trends

4. Urinary Tract Infection Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Urinary Tract Infection Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Urinary Tract Infection Therapeutics Market Landscape

  • 6.1. Urinary Tract Infection Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Urinary Tract Infection Therapeutics Market - By Drug

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug, 2022 & 2030 (%)
    • 7.1.2. Penicillin and Combinations
    • 7.1.3. Quinolones
    • 7.1.4. Cephalosporin
    • 7.1.5. Azoles and Amphotericin B
    • 7.1.6. Nitrofurans
    • 7.1.7. Others

8. Urinary Tract Infection Therapeutics Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2022 & 2030 (%)
    • 8.1.2. Complicated UTI
    • 8.1.3. Uncomplicated UTI
    • 8.1.4. Others

9. Urinary Tract Infection Therapeutics Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 9.1.2. Hospital
    • 9.1.3. Pharmacies
    • 9.1.4. Gynecology and Urology Clinics

10. Urinary Tract Infection Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Urinary Tract Infection Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Urinary Tract Infection Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Urinary Tract Infection Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Urinary Tract Infection Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Urinary Tract Infection Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drug, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Urinary Tract Infection Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AstraZeneca
    • 11.2.2. GlaxoSmithKline
    • 11.2.3. Merck & Co., Inc.
    • 11.2.4. Pfizer Inc.
    • 11.2.5. Allergan
    • 11.2.6. Novartis
    • 11.2.7. Bayer AG
    • 11.2.8. Johnson & Johnson
    • 11.2.9. Ferring Pharmaceuticals
    • 11.2.10. Cipla
    • 11.2.11. Sun Pharmaceutical Industries
    • 11.2.12. Lupin Limited
    • 11.2.13. Teva Pharmaceuticals
    • 11.2.14. Dr. Reddy's Laboratories
    • 11.2.15. Zydus Cadila

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data Indications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Urinary Tract Infection Therapeutics Market: Drug Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Drug 2018-2030 (USD Million)
  • TABLE Urinary Tract Infection Therapeutics Market: Indication Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Indication 2018-2030 (USD Million)
  • TABLE Urinary Tract Infection Therapeutics Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE Urinary Tract Infection Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Urinary Tract Infection Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE North America Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Europe Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Latin America Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Drug, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Indication, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Therapeutics Market, by Distribution Channel, 2018-2030 (USD Million)

List of Figures

  • FIGURE Urinary Tract Infection Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug segment market share analysis, 2022 & 2030
  • FIGURE Drug segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indication segment market share analysis, 2022 & 2030
  • FIGURE Indication segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Distribution Channel segment market share analysis, 2022 & 2030
  • FIGURE Distribution Channel segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Europe Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Urinary Tract Infection Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE India Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Urinary Tract Infection Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Urinary Tract Infection Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)